$0.008

Want access to our research and new buy ideas?

Take a free 15 day trial - no credit card required.

Start your free trial now

ACL General Information

Alchemia Limited
ACL
http://www.alchemia.com.au
Biotechnology
3
325

ACL Current Share Price+

Current Price $0.008
Open $0.008
High $0.008
Low $0.008
Last Close $0.008
Volume 261232
Price Movement - ( No change )
  • +Security prices are delayed by at least 20 minutes and are indicative only.

ACL Company Overview

Business Description

Alchemia Limited (ACL) is a biotechnology company which develops new human therapeutics based on its proprietary drug discovery and expands drug targeting and synthesis technologies in Australia and USA.

ACL Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2017 A -0.54 -0.20 0.00% 0.00 0.00 0.00% 0.0%
2016 A -3.21 -1.00 0.00% 0.00 0.00 0.00% 0.0%
2015 A -1.58 -0.50 0.00% 0.00 0.00 0.00% 0.0%

ACL Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2015 A 2016 A 2017 A 2015 A 2016 A 2017 A 2015 A 2016 A 2017 A
Alchemia (ACL) $3M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
CSL (CSL) $97,076M 0.3524 0.1588 0.1059 41.6369 35.9310 32.4914 1.08% 1.25% 1.40%
Mesoblast (MSB) $796M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Monash IVF Group (MVF) $280M 0.0229 -0.2136 0.2116 9.5200 12.1058 9.9916 7.39% 5.78% 7.01%
Sirtex Medical (SRX) $1,762M 0.2975 -0.1653 0.1170 26.3981 31.6243 28.3127 0.95% 1.36% 1.52%

ACL Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 1.18 0.00
Market 1.05 17.00 1.60 1.59
Sector 0.71 19.10 3.82 2.92

ACL Directors

Name Position Start Date
Mr Simon Gennari Non-Executive Chairman, Non-Executive Director 26 Feb 2016
Mr Darren Rael Book Non-Executive Director 12 Dec 2016
Mr Cameron Petricevic Non-Executive Director 6 Jun 2018

ACL Management

Name Position
Melanie Jaye Leydin Company Secretary

ACL Substantial Shareholders

Holding Name
39,426,777 (12.14%) Shomron Pty Ltd
30,800,000 (9.48%) Aust Executor Trustees Ltd

ACL Calendar of Events

Date Event
20 February 2019 Report (Interim)
22 August 2018 Report (Annual)
22 August 2018 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.